Please ensure Javascript is enabled for purposes of website accessibility

Big Data's Big Future in Health Care

By Michael Douglass and Dave Williamson - Jun 8, 2014 at 1:13PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

How big data could make a huge difference in health and profitability.

Big data is a major potential area of opportunity in health care.

And investors would do well to keep a close eye on it. Especially when companies start putting serious money behind decisions made based on predictive analytics.

Cigna (CI), for example, recently signed a deal with AstraZeneca (AZN -0.61%) which could have big implications for both companies. Cigna will allow AstraZeneca's statin Crestor to be prescribed without prior authorization provided its computer model indicates that the patient is at a higher risk of atherosclerosis. This would help assure that members who need to go straight on Crestor -- instead of another statin -- are able to move to Crestor quickly. Typically, members have to go through traditional "step therapy" where they must try cheaper generics first.

Of course, IBM (IBM 0.58%) is a major player with Watson and its incredible potential to help identify appropriate treatment regimens with big data.

In the video below, from Market Checkup, the Motley Fool's health care-focused investing show, health care analysts Michael Douglass and David Williamson talk about big data and the exciting opportunities in this area.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

International Business Machines Corporation Stock Quote
International Business Machines Corporation
IBM
$142.89 (0.58%) $0.83
AstraZeneca PLC Stock Quote
AstraZeneca PLC
AZN
$66.49 (-0.61%) $0.41
Cigna Corporation Stock Quote
Cigna Corporation
CI

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
336%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.